Patent · US Active

Treatment of dry eye

US9572811B2 · kind B2 · utility

15Cited by
0References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 31, 2013
Grant dateFeb 21, 2017
Priority date
Expiry dateJul 31, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P27/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides a method of treating dry eye by inhibition of Bruton's tyrosine kinase (hereinafter “BTK”) inhibitors, pharmaceutical formulations comprising the same, and processes for preparing such compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.